IP Verse

Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence Seizure

Patent No. EP3711758 (titled "Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence Seizure") was filed by SK Biopharmaceuticals on Nov 13, 2018. The application was issued on Mar 27, 2024.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DENNEMEYER & ASSOCIATESDec 20, 2024DENNEMEYER & ASSOCIATES
HAMM&WITTKOPP PATENTANWÄLTE PARTMBBDec 13, 2024HAMM&WITTKOPP PATENTANWÄLTE PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3711758

SK BIOPHARMACEUTICALS
Application Number
EP18878222A
Filing Date
Nov 13, 2018
Status
Granted And Under Opposition
Feb 23, 2024
Publication Date
Mar 27, 2024
External Links
Slate, Register , Google Patents